JP2023525758A5 - - Google Patents
Info
- Publication number
- JP2023525758A5 JP2023525758A5 JP2022567883A JP2022567883A JP2023525758A5 JP 2023525758 A5 JP2023525758 A5 JP 2023525758A5 JP 2022567883 A JP2022567883 A JP 2022567883A JP 2022567883 A JP2022567883 A JP 2022567883A JP 2023525758 A5 JP2023525758 A5 JP 2023525758A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- aryl
- heteroaryl
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063021797P | 2020-05-08 | 2020-05-08 | |
| US63/021,797 | 2020-05-08 | ||
| PCT/US2021/031372 WO2021226510A2 (en) | 2020-05-08 | 2021-05-07 | Akt3 modulators and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023525758A JP2023525758A (ja) | 2023-06-19 |
| JP2023525758A5 true JP2023525758A5 (cg-RX-API-DMAC7.html) | 2024-05-16 |
Family
ID=78468492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567883A Pending JP2023525758A (ja) | 2020-05-08 | 2021-05-07 | Ａｋｔ３モジュレーターおよびその使用方法 |
Country Status (12)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021212111A1 (en) * | 2020-04-17 | 2021-10-21 | Augusta University Research Institute, Inc. | Compositions and methods for treating leukemia |
| US20230295114A1 (en) * | 2020-05-08 | 2023-09-21 | Georgiamune Llc | Akt3 modulators |
| CN115867562A (zh) * | 2020-05-08 | 2023-03-28 | 乔治穆内有限责任公司 | Akt3调节剂 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03001256A (es) * | 2000-08-11 | 2004-12-06 | Vertex Pharma | Inhibidores de p38. |
| DE602004026047D1 (de) * | 2003-04-24 | 2010-04-29 | Merck Sharp & Dohme | Hemmer der akt aktivität |
| EP2078008A2 (en) * | 2006-10-12 | 2009-07-15 | SuperGen, Inc. | Quinoline derivatives for modulating dna methylation |
| AR064010A1 (es) * | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| US7790746B2 (en) * | 2007-10-12 | 2010-09-07 | Supergen, Inc. | Quinoline derivatives for modulating DNA methylation |
| US7939546B2 (en) * | 2007-10-12 | 2011-05-10 | Supergen, Inc. | Quinoline derivatives for modulating DNA methylation |
| GB201207722D0 (en) * | 2012-05-02 | 2012-06-13 | Bergenbio As | Method |
| US9707278B2 (en) * | 2014-04-17 | 2017-07-18 | Augusta University Research Institute, Inc. | Methods of modulating immune responses by modifying Akt3 bioactivity |
| US10292978B2 (en) * | 2016-01-15 | 2019-05-21 | Augusta University Research Institute, Inc. | Specific Akt3 inhibitor and uses thereof |
| US10342868B2 (en) * | 2016-01-15 | 2019-07-09 | Augusta University Research Institute, Inc. | Methods and compositions for inhibiting Akt3 |
| US20210208778A1 (en) * | 2017-06-29 | 2021-07-08 | Hewlett-Packard Development Company, L.P. | Contiguous planar display operable to have area functioning as primary display and area functioning as secondary display |
| EP3678666B1 (en) * | 2017-09-07 | 2025-07-09 | Augusta University Research Institute, Inc. | Specific akt3 activator and uses thereof |
-
2021
- 2021-05-07 BR BR112022022327A patent/BR112022022327A2/pt unknown
- 2021-05-07 IL IL297596A patent/IL297596A/en unknown
- 2021-05-07 CN CN202180046157.6A patent/CN115956078A/zh active Pending
- 2021-05-07 MX MX2022014019A patent/MX2022014019A/es unknown
- 2021-05-07 EP EP21800335.8A patent/EP4146196A4/en active Pending
- 2021-05-07 WO PCT/US2021/031372 patent/WO2021226510A2/en not_active Ceased
- 2021-05-07 KR KR1020227042831A patent/KR20230019109A/ko active Pending
- 2021-05-07 JP JP2022567883A patent/JP2023525758A/ja active Pending
- 2021-05-07 AU AU2021269065A patent/AU2021269065A1/en active Pending
- 2021-05-07 CA CA3182675A patent/CA3182675A1/en active Pending
- 2021-05-07 US US17/923,696 patent/US20230181563A1/en active Pending
- 2021-05-07 PH PH1/2022/553026A patent/PH12022553026A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2879677B1 (en) | Substituted pyrazolone compounds and methods of use | |
| EP2680886B1 (en) | Substituted quinoline compounds | |
| Liu et al. | Autophagy, a double-edged sword in anti-angiogenesis therapy | |
| US8481001B2 (en) | Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer | |
| US8975282B2 (en) | Substituted pyrazolone compounds and methods of use | |
| JP2015520753A5 (cg-RX-API-DMAC7.html) | ||
| JP2013507453A5 (cg-RX-API-DMAC7.html) | ||
| US20160287564A1 (en) | Methods of administering glutaminase inhibitors | |
| JP2015523397A (ja) | Ｃｄｋ４／６阻害剤およびｂ−ｒａｆ阻害剤の組合せ医薬 | |
| AU2012223639A1 (en) | Substituted quinoline compounds and methods of use | |
| JP2014533272A (ja) | 増殖性疾患の治療方法 | |
| JP7199502B2 (ja) | 治療用複素環式化合物 | |
| TW202214243A (zh) | 西奧羅尼聯合免疫檢查點抑製劑在抗腫瘤治療中的應用 | |
| PH12019500615A1 (en) | 5-[2-(PYRIDIN-2-YLAMINO)-1,3-THIAZOL-5-YL]-2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND THEIR USE AS DUAL INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE DELTA and GAMMA | |
| CN108367000A (zh) | 用于乳腺癌的治疗剂 | |
| US11840523B2 (en) | IRE1α inhibitors and uses thereof | |
| JP6367038B2 (ja) | 受容体の細胞内輸送制御による白血病治療のための新規医薬組成物 | |
| KR20160006669A (ko) | 5-브로모-인디루빈 | |
| TW202014184A (zh) | 用於治療癌症之組合 | |
| WO2021210636A1 (ja) | 乳がん治療剤 | |
| US20210179591A1 (en) | New compounds for use as a therapeutically active substance and in particular for use in the treatment of tumors | |
| TW202535405A (zh) | 用於藉由增強數類已核准藥物的作用以治療癌症之alc1抑制劑 | |
| JP2023539775A (ja) | 疾患、障害又は状態の処置のための細胞組成物及び使用方法 | |
| JP2022513375A5 (cg-RX-API-DMAC7.html) | ||
| Li et al. | Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells |